Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(1-carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagine
- Development stage
- Unknown
- Modality
- Peptides, Small Molecules
01
Overview
N-(1-carboxy–3–phenylpropyl)phenylalanyl-alpha-asparagine is a synthetic tripeptide small molecule, classified as an experimental compound. It has been studied primarily as a peptide-based inhibitor of elastase, particularly the elastase enzyme from Pseudomonas aeruginosa. Elastase is a proteolytic enzyme involved in tissue degradation and bacterial virulence; thus, inhibitors like this compound are of interest for potential anti-infective or anti-inflammatory applications. There are no approved indications or marketed products containing this molecule[2][3][4].
- Other names
- N-(1-carboxy-3-phenylpropyl)phenylalanyl-asparagineN-(1-CARBOXY-3-PHENYLPROPYL)PHENYLALANYL-alpha-ASPARAGINE(2S)-2-{[(1S)-1-carbamoyl‑2‑carboxyethyl]carbamoyl}-2‑phenylethyl]amino}-4‑phenylbutanoic acidN-[ (1S)-1-carboxy‑3‑phenylpropyl ] -L‑phenylalanyl-L-alpha-asparagine
02
Targets
LasB (Pseudomonas aeruginosa elastase)
Beyond the preview
Go deeper on N-(1-carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-(1-carboxy-3-phenylpropyl)phenylalanyl-alpha-asparagine.